BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 3137045)

  • 41. The importance and frequency of mixed infections with Chlamydia trachomatis and mycoplasmas in acute gonococcal urethritis.
    Jahn G; Bialasiewicz AA; Jenisch A; Blenk H
    S Afr Med J; 1984 Mar; 65(12):462-7. PubMed ID: 6701710
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ureaplasma-infected human sperm in infertile men.
    Grossgebauer K; Hennig A
    Arch Androl; 1984; 12 Suppl():35-41. PubMed ID: 6535453
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae.
    Welsh LE; Gaydos CA; Quinn TC
    Antimicrob Agents Chemother; 1992 Feb; 36(2):291-4. PubMed ID: 1318677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Partial efficacy of clindamycin against Chlamydia trachomatis in men with nongonococcal urethritis.
    Bowie WR; Yu JS; Jones HD
    Sex Transm Dis; 1986; 13(2):76-80. PubMed ID: 3520885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Susceptibility of Ureaplasma urealyticum to ten chemotherapeutic agents.
    Sobetzko R; Hartmann AA; Elsner P
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Aug; 269(2):245-50. PubMed ID: 2973712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antimicrobial activity of Manuka honey against antibiotic-resistant strains of the cell wall-free bacteria Ureaplasma parvum and Ureaplasma urealyticum.
    Hillitt KL; Jenkins RE; Spiller OB; Beeton ML
    Lett Appl Microbiol; 2017 Mar; 64(3):198-202. PubMed ID: 27992658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of nongonococcal urethritis with rifampicin as a means of defining the role of Ureaplasma urealyticum.
    Coufalik ED; Taylor-Robinson D; Csonka GW
    Br J Vener Dis; 1979 Feb; 55(1):36-43. PubMed ID: 371746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Significance of Ureaplasma urealyticum and Clostridium difficile in nongonococcal urethritis].
    Katoh N
    Kansenshogaku Zasshi; 1985 Jul; 59(7):687-700. PubMed ID: 3932554
    [No Abstract]   [Full Text] [Related]  

  • 49. Differential response of chlamydial and ureaplasma-associated urethritis to sulphafurazole (sulfisoxazole) and aminocyclitols.
    Bowie WR; Floyd JF; Miller Y; Alexander ER; Holmes J; Holmes KK
    Lancet; 1976 Dec; 2(7998):1276-8. PubMed ID: 63748
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In-vitro activity of roxithromycin against Chlamydia trachomatis.
    Moroni A; Sambri V; Rumpianesi F; Donati M; Cevenini R
    J Chemother; 1991 Jan; 3 Suppl 1():28-9. PubMed ID: 12041779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro activity of dirithromycin against Chlamydia trachomatis.
    Segreti J; Kapell KS
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2213-4. PubMed ID: 7811051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin.
    Samra Z; Rosenberg S; Dan M
    J Chemother; 2011 Apr; 23(2):77-9. PubMed ID: 21571622
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rosaramicin and tetracycline in the treatment of non-gonococcal urethritis. A comparison of clinical and microbiological results.
    Darne JF; Ridgway GL; Oriel JD
    Br J Vener Dis; 1982 Apr; 58(2):117-20. PubMed ID: 7039760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Analysis of the infection status and the drug resistance of mycoplasma and chlamydiae in genitourinary tracts of children with suspected nongonococcal urethritis].
    Wang Y; Yang WB; Yuan HY; Zhang QX; Zhu XY
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):62-4. PubMed ID: 19573386
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae.
    Agacfidan A; Moncada J; Schachter J
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1746-8. PubMed ID: 8239579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of men with urethritis negative for Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum.
    Maeda S; Tamaki M; Kubota Y; Nguyen PB; Yasuda M; Deguchi T
    Int J Urol; 2007 May; 14(5):422-5. PubMed ID: 17511725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis.
    Walsh M; Kappus EW; Quinn TC
    Antimicrob Agents Chemother; 1987 May; 31(5):811-2. PubMed ID: 3038010
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A preliminary study of clarithromycin versus doxycycline in the treatment of nongonococcal urethritis and mucopurulent cervicitis.
    Stein GE; Mummaw NL; Havlichek DH
    Pharmacotherapy; 1995; 15(6):727-31. PubMed ID: 8602379
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Susceptibilities of Neisseria gonorrhoeae and Ureaplasma urealyticum isolates from male patients with urethritis to several antibiotics including telithromycin.
    Aydin D; Küçükbasmaci O; Gonullu N; Aktaş Z
    Chemotherapy; 2005 May; 51(2-3):89-92. PubMed ID: 15886468
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [In vitro, activity of a new macrolide (RU 28965) against Chlamydia trachomatis and Ureaplasma urealyticum].
    Sambri V; Rumpianesi F; Franchi L; Cevenini R
    G Ital Chemioter; 1985; 32(1):175-6. PubMed ID: 3830774
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.